MUMBAI, India, Feb. 27 -- Intellectual Property India has published a patent application (202641018304 A) filed by Dr. Srinivas Mulkalapalli; Dr. D. Chitra; Dr. Ghazala Sultan; Ch Sree Kumar; and Sandhya Rani Biswal, Hyderabad, Telangana, on Feb. 18, for 'a deep learning and explainable ai-based multi-omics fusion framework for mapping mechanistic pathways in drug-induced gut-liver crosstalk alterations.'

Inventor(s) include Dr. Srinivas Mulkalapalli; Dr. D. Chitra; Dr. Ghazala Sultan; Ch Sree Kumar; and Sandhya Rani Biswal.

The application for the patent was published on Feb. 27, under issue no. 09/2026.

According to the abstract released by the Intellectual Property India: "The present invention discloses a deep learning and explainabl...